Published in J Mol Cell Cardiol on January 01, 1999
Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease). Prog Cardiovasc Dis (2009) 1.60
Current understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas disease. Semin Immunopathol (2012) 1.26
Thromboxane A2 is a key regulator of pathogenesis during Trypanosoma cruzi infection. J Exp Med (2007) 1.21
Infection of endothelial cells with Trypanosoma cruzi activates NF-kappaB and induces vascular adhesion molecule expression. Infect Immun (1999) 1.21
Microarray analysis of changes in gene expression in a murine model of chronic chagasic cardiomyopathy. Parasitol Res (2003) 1.19
Current status of cardiac MRI in small animals. MAGMA (2004) 1.17
Bone marrow cell therapy ameliorates and reverses chagasic cardiomyopathy in a mouse model. J Infect Dis (2008) 1.16
Role of endothelin 1 in the pathogenesis of chronic chagasic heart disease. Infect Immun (2005) 1.15
Trypanosoma cruzi infection of cultured adipocytes results in an inflammatory phenotype. Obesity (Silver Spring) (2008) 1.12
Response of adipose tissue to early infection with Trypanosoma cruzi (Brazil strain). J Infect Dis (2012) 1.09
Nitric oxide synthase-2 modulates chemokine production by Trypanosoma cruzi-infected cardiac myocytes. Microbes Infect (2008) 1.08
Activation of transcription factors AP-1 and NF-kappa B in murine Chagasic myocarditis. Infect Immun (2003) 1.07
Pathology affects different organs in two mouse strains chronically infected by a Trypanosoma cruzi clone: a model for genetic studies of Chagas' disease. Infect Immun (2004) 1.03
Chagas heart disease: report on recent developments. Cardiol Rev (2012) 1.02
Crucial role of the central leptin receptor in murine Trypanosoma cruzi (Brazil strain) infection. J Infect Dis (2010) 0.98
Alterations in myocardial gene expression associated with experimental Trypanosoma cruzi infection. Genomics (2008) 0.97
Aspirin treatment of mice infected with Trypanosoma cruzi and implications for the pathogenesis of Chagas disease. PLoS One (2011) 0.97
Coronary microvascular disease in chronic Chagas cardiomyopathy including an overview on history, pathology, and other proposed pathogenic mechanisms. PLoS Negl Trop Dis (2010) 0.97
Magnetic resonance imaging in experimental Chagas disease: a brief review of the utility of the method for monitoring right ventricular chamber dilatation. Parasitol Res (2005) 0.96
Effects of early and late verapamil administration on the development of cardiomyopathy in experimental chronic Trypanosoma cruzi (Brazil strain) infection. Parasitol Res (2004) 0.94
Trypanosoma cruzi induces changes in cardiac connexin43 expression. Microbes Infect (2007) 0.94
Mesenchymal bone marrow cell therapy in a mouse model of chagas disease. Where do the cells go? PLoS Negl Trop Dis (2012) 0.93
Bioactive lipids in Trypanosoma cruzi infection. Adv Parasitol (2011) 0.93
Fas-FasL interaction modulates nitric oxide production in Trypanosoma cruzi-infected mice. Immunology (2001) 0.91
Cell-specific activation of nuclear factor-kappaB by the parasite Trypanosoma cruzi promotes resistance to intracellular infection. Mol Biol Cell (2000) 0.89
Risedronate in the treatment of Murine Chagas' disease. Parasitol Res (2005) 0.89
Alterations in glucose homeostasis in a murine model of Chagas disease. Am J Pathol (2013) 0.89
Dyskinesis in Chagasic myocardium: centerline analysis of wall motion using cardiac-gated magnetic resonance images of mice. Magn Reson Imaging (2006) 0.89
Micro-positron emission tomography in the evaluation of Trypanosoma cruzi-induced heart disease: Comparison with other modalities. Am J Trop Med Hyg (2009) 0.89
Inducible nitric oxide synthase is not essential for control of Trypanosoma cruzi infection in mice. Infect Immun (2004) 0.89
A magnetic resonance imaging study of intestinal dilation in Trypanosoma cruzi-infected mice deficient in nitric oxide synthase. Am J Trop Med Hyg (2008) 0.88
New drugs for neglected infectious diseases: Chagas' disease. Br J Pharmacol (2010) 0.88
Differential regulation of nitric oxide synthase isoforms in experimental acute chagasic cardiomyopathy. Clin Exp Immunol (2000) 0.86
Experimental chemotherapy against Trypanosoma cruzi infection using ruthenium nitric oxide donors. Antimicrob Agents Chemother (2009) 0.86
Endothelin-1 and its role in the pathogenesis of infectious diseases. Life Sci (2014) 0.86
Molecular imaging, biodistribution and efficacy of mesenchymal bone marrow cell therapy in a mouse model of Chagas disease. Microbes Infect (2014) 0.86
Role of NO synthase in the development of Trypanosoma cruzi-induced cardiomyopathy in mice. Am J Trop Med Hyg (2009) 0.85
Perforin-expressing cytotoxic cells contribute to chronic cardiomyopathy in Trypanosoma cruzi infection. Int J Exp Pathol (2009) 0.84
Caspase-1/ASC inflammasome-mediated activation of IL-1β-ROS-NF-κB pathway for control of Trypanosoma cruzi replication and survival is dispensable in NLRP3-/- macrophages. PLoS One (2014) 0.84
Advances in imaging of animal models of Chagas disease. Adv Parasitol (2011) 0.83
Trypanosoma cruzi infection results in the reduced expression of caveolin-3 in the heart. Cell Cycle (2010) 0.82
NADPH phagocyte oxidase knockout mice control Trypanosoma cruzi proliferation, but develop circulatory collapse and succumb to infection. PLoS Negl Trop Dis (2012) 0.81
Trypanosoma cruzi infection: do distinct populations cause intestinal motility alteration? Parasitol Res (2010) 0.80
Pentoxifylline reverses chronic experimental Chagasic cardiomyopathy in association with repositioning of abnormal CD8+ T-cell response. PLoS Negl Trop Dis (2015) 0.79
Depletion of regulatory T cells decreases cardiac parasitosis and inflammation in experimental Chagas disease. Parasitol Res (2015) 0.79
Recent developments in the interactions between caveolin and pathogens. Adv Exp Med Biol (2012) 0.78
The vasculature in chagas disease. Adv Parasitol (2011) 0.78
Imaging the Gastrointestinal Tract of Small Animals. J Neuroparasitology (2010) 0.76
Microarray analysis of the mammalian thromboxane receptor-Trypanosoma cruzi interaction. Cell Cycle (2011) 0.76
Role of cyclooxygenase-2 in Trypanosoma cruzi survival in the early stages of parasite host-cell interaction. Mem Inst Oswaldo Cruz (2015) 0.75
An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med (1993) 18.56
Immunology of tuberculosis. Annu Rev Immunol (2001) 14.26
Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity (1995) 10.65
Toxoplasma gondii: from animals to humans. Int J Parasitol (2000) 10.45
Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA (1996) 7.03
Scaling ADLs within the MDS. J Gerontol A Biol Sci Med Sci (1999) 6.96
Gene Ontology annotations and resources. Nucleic Acids Res (2012) 6.13
Stimulation of bone formation in vitro and in rodents by statins. Science (1999) 5.55
Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol (1987) 5.33
Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages. Science (1993) 5.20
Keratin expression in human tissues and neoplasms. Histopathology (2002) 4.91
Clear cell tumor of the lung. Immunohistochemical and ultrastructural evidence of melanogenesis. Am J Surg Pathol (1991) 4.48
Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol (2000) 4.46
Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology (2002) 4.22
Sonic hedgehog--regulated oligodendrocyte lineage genes encoding bHLH proteins in the mammalian central nervous system. Neuron (2000) 4.17
Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol (1992) 4.04
Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society. Med Pediatr Oncol (1997) 3.83
Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice. Proc Natl Acad Sci U S A (2003) 3.53
Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis. Infect Immun (2000) 3.39
Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. BMJ (1995) 3.37
Epstein-Barr virus-associated gastric adenocarcinoma. Am J Pathol (1992) 3.33
Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease. N Engl J Med (1995) 3.31
Depletion of CD4(+) T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2. J Exp Med (2000) 3.20
Tuberculosis: latency and reactivation. Infect Immun (2001) 3.15
Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. N Engl J Med (1992) 2.98
Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology. Infect Immun (2001) 2.94
Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis. Cardiovasc Res (1994) 2.91
Effects of aminoguanidine on latent murine tuberculosis. J Immunol (1998) 2.83
Clathrin-coated vesicles in nervous tissue are involved primarily in synaptic vesicle recycling. J Cell Biol (1992) 2.59
Oxygenated mycolic acids are necessary for virulence of Mycobacterium tuberculosis in mice. Mol Microbiol (2000) 2.59
Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol (1984) 2.53
Electromagnetically induced transparency and slow light with optomechanics. Nature (2011) 2.41
Polyamine metabolism: a potential therapeutic target in trypanosomes. Science (1980) 2.41
Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration. Lymphoepithelioma-like carcinoma. Am J Pathol (1991) 2.37
GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes. Nat Med (1997) 2.37
Retracted Infectious measles virus from cloned cDNA. EMBO J (1990) 2.36
Body mass index, waist circumference and waist:hip ratio as predictors of cardiovascular risk--a review of the literature. Eur J Clin Nutr (2009) 2.35
Chagas' disease. Clin Microbiol Rev (1992) 2.30
Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med (1993) 2.27
Reactivation of latent tuberculosis: variations on the Cornell murine model. Infect Immun (1999) 2.26
Cardiac defects and renal failure in mice with targeted mutations in Pkd2. Nat Genet (2000) 2.24
Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: frequency of Epstein-Barr virus and other features associated with immunosuppression. Hum Pathol (1994) 2.23
Hippocampal sclerosis: a common pathological feature of dementia in very old (> or = 80 years of age) humans. Acta Neuropathol (1994) 2.23
Frequent presence of the Epstein-Barr virus in inflammatory pseudotumor. Hum Pathol (1995) 2.22
Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide-activated macrophages. Proc Natl Acad Sci U S A (1992) 2.20
SUP-HD1: a new Hodgkin's disease-derived cell line with lymphoid features produces interferon-gamma. Blood (1989) 2.17
Rescue of synthetic measles virus minireplicons: measles genomic termini direct efficient expression and propagation of a reporter gene. Virology (1995) 2.11
Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma. Am J Pathol (1987) 2.10
Splenic vascular tumors: a histologic, immunophenotypic, and virologic study. Am J Surg Pathol (1997) 2.09
A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic heart disease. Circulation (1990) 2.05
Cl(-)-channel blockers in the thick ascending limb of the loop of Henle. Structure activity relationship. Pflugers Arch (1986) 2.04
New developments in the pathologic diagnosis of adrenal cortical neoplasms. A review. Am J Clin Pathol (1992) 2.02
Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation. N Engl J Med (1988) 1.99
Survival of reproductive behaviors in estrogen receptor beta gene-deficient (betaERKO) male and female mice. Proc Natl Acad Sci U S A (1999) 1.99
Macrophages and control of granulomatous inflammation in tuberculosis. Mucosal Immunol (2011) 1.98
What is the role of nitric oxide in murine and human host defense against tuberculosis?Current knowledge. Am J Respir Cell Mol Biol (2001) 1.98
Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis. QJM (2005) 1.97
In vivo effects of difluoromethylornithine on trypanothione and polyamine levels in bloodstream forms of Trypanosoma brucei. Mol Biochem Parasitol (1987) 1.97
Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy. J Clin Invest (1999) 1.95
MLK-3 activates the SAPK/JNK and p38/RK pathways via SEK1 and MKK3/6. EMBO J (1996) 1.92
The role of Epstein-Barr virus in lymphoepithelioma-like carcinomas. Am J Clin Pathol (1995) 1.92
Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases. Mod Pathol (2001) 1.91
Carcinomas with metaplasia and sarcomas of the breast. Am J Clin Pathol (1991) 1.89
Expression of inositol trisphosphate receptors. Cell Calcium (1999) 1.88
Detection of Epstein-Barr Virus in inflammatory pseudotumor. Semin Diagn Pathol (1998) 1.86
Laparoscopic splenectomy: outcome and efficacy in 103 consecutive patients. Ann Surg (1998) 1.85
Epstein-Barr virus-associated non-Hodgkin's lymphoma in patients infected with the human immunodeficiency virus. Blood (1993) 1.82
Trypanosoma cruzi: role of the immune response in the natural resistance of inbred strains of mice. Exp Parasitol (1978) 1.82
Analysis of naturally occurring delayed-type hypersensitivity reactions in leprosy by in situ hybridization. J Exp Med (1989) 1.82
A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy. J Clin Invest (1998) 1.77
Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues. Diagn Mol Pathol (1992) 1.75
Cure of Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense infections in mice with an irreversible inhibitor of S-adenosylmethionine decarboxylase. Antimicrob Agents Chemother (1990) 1.74
Studies of in vitro infection by Trypanosoma cruzi. I. Ultrastructural studies on the invasion of macrophages and L-cells. Am J Trop Med Hyg (1975) 1.74
The inducible nitric oxide synthase locus confers protection against aerogenic challenge of both clinical and laboratory strains of Mycobacterium tuberculosis in mice. Infect Immun (2001) 1.73
Small subunit rRNA sequence of Enterocytozoon bieneusi and its potential diagnostic role with use of the polymerase chain reaction. J Infect Dis (1993) 1.73
Utility of microsporidian rRNA in diagnosis and phylogeny: a review. Folia Parasitol (Praha) (1994) 1.72
Nasal lymphomas in Peru. High incidence of T-cell immunophenotype and Epstein-Barr virus infection. Am J Surg Pathol (1993) 1.71
In vitro assessment of antimicrobial agents against Toxoplasma gondii. J Infect Dis (1988) 1.71
Laparoscopic management of benign solid and cystic lesions of the liver. Ann Surg (1999) 1.70
In vivo effects of alpha-DL-difluoromethylornithine on the metabolism and morphology of Trypanosoma brucei brucei. Mol Biochem Parasitol (1983) 1.69
Clonal rearrangements of T-cell receptor genes in mycosis fungoides and dermatopathic lymphadenopathy. N Engl J Med (1985) 1.68
Ocular and orbital cysticercosis. Acta Ophthalmol Scand (2001) 1.66
Gamma interferon-induced inhibition of Toxoplasma gondii in astrocytes is mediated by IGTP. Infect Immun (2001) 1.66
Review and hypothesis: the eosinophil and peripartum heart disease (myocarditis and coronary artery dissection)--coincidence or pathogenetic significance? Cardiovasc Res (1997) 1.65
Neurofibroma and cellular neurofibroma with atypia: a report of 14 tumors. Am J Surg Pathol (1997) 1.62
Calcium-induced structural transition in the regulatory domain of human cardiac troponin C. Biochemistry (1997) 1.61
Expression of the beta (slow)-isoform of MHC in the adult mouse heart causes dominant-negative functional effects. Am J Physiol Heart Circ Physiol (2000) 1.60
Chronic lymphocytic leukemia/small lymphocytic lymphoma with Reed-Sternberg-like cells and possible transformation to Hodgkin's disease. Mediation by Epstein-Barr virus. Am J Surg Pathol (1992) 1.60
Activity of roxithromycin (RU 28965), a macrolide, against Toxoplasma gondii infection in mice. Antimicrob Agents Chemother (1986) 1.59
Disseminated strongyloidiasis with central nervous system involvement diagnosed antemortem in a patient with acquired immunodeficiency syndrome and Burkitts lymphoma. Cancer (1990) 1.59
Development of Kaposi's sarcoma despite sustained suppression of HIV plasma viremia. J Acquir Immune Defic Syndr (1999) 1.59
The localization of the brain-specific inorganic phosphate transporter suggests a specific presynaptic role in glutamatergic transmission. J Neurosci (1998) 1.58
Immunopathologic and molecular studies as an aid to the diagnosis of malignant mesothelioma. Hum Pathol (1992) 1.58